Helicobacter pylori infection occurs in more than half of the world's population and is the main cause for gastric cancer. A series of lifestyle and nutritional factors, such as tobacco smoking and obesity, have been found to elevate the risk for cancer development. In this study, we sought to determine the immunological aspects during H. pylori infection and gastric cancer development. We found that B cells from H. pylori-infected patients presented altered composition and function compared to uninfected patients. IL-10-expressing CD24 + CD38 + B cells were upregulated in H. pylori-infected patients, contained potent regulatory activity in inhibiting T cell pro-inflammatory cytokine secretion, and responded directly to H. pylori antigen stimulation. Interestingly, in H. pylori-infected smoking subjects and obese subjects, the number of IL-10 + B cells and CD24 + CD38 + B cells were reduced compared to H. pylori-infected asymptomatic subjects. Regulatory functions mediated by CD24 + CD38 + B cells were also impaired. In addition, gastric cancer positive patients had reduced IL-10-producing B cell frequencies after H. pylori-stimulation. Altogether, these data suggest that in H. pylori-infection, CD24 + CD38 + B cell is upregulated and plays a role in suppressing pro-inflammatory responses, possibly through IL-10 production, a feature that was not observed in smoking and obese patients.
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Introduction
Helicobacter pylori (H. pylori) is a kind of Gram-negative pathogenic bacteria found in more than half of the world's population and preferentially inhibits the upper gastrointestinal tract, including the stomach epithelium and the duodenum tract [1, 2] . Although the vast majority (>80%) of infections are asymptomatic, 10-20% infected subjects will develop peptic ulcers while 1-2% will acquire gastric cancer [3] . The precise mechanism of cancer development as a result of H. pylori infection is not well defined, but chronic untreated inflammation in the upper gastrointestinal tract is thought to contribute to the continued damage of the stomach epithelium [4, 5] . Specifically, inflammationassociated signaling molecules, such as tumor necrosis factor alpha (TNF-a), have been found to promote gastric tumorigenesis and is upregulated in H. pylori infection [6] . Other pro-inflammatory cytokines secreted by T cells, including IL-2, IL-17, and interferon gamma (IFN-g), are also upregulated in H. pylori infection and are associated with increased risk of gastric tumorigenesis [7] [8] [9] [10] . A series of other factors, such as continuous exposure to tobacco smoking and obesity, are positively correlated with increased gastric cancer risk, though the underlying mechanism is unclear [3, 11] . Recently, the role of tolerance-inducing B cells has been characterized in a series of infectious diseases and autoimmune diseases [12] . In mice, CD1d hi CD5 + B cells have been found to help establish tolerogenic environment in tissues and have a role in preventing autoimmune induction [13] . In humans, CD19 + CD24 hi CD38 hi B cells have similar tolerance-inducing role in healthy as well as HBV-infected individuals [14] ; the onset of autoimmune disease is correlated with loss of regulatory function in this B cell subset [15] . IL-10 is a pleiotropic immunoregulatory cytokine that is capable of inhibiting a series of pro-inflammatory cytokines, including IL-2, IL-17, IFN-g and TNF-a, and is shown to potently suppress the antigen-presenting capacity of antigen presenting cells [16] . Central to all tolerance-inducing B cell subsets, IL-10 production is pivotal to B cell-mediated regulation in suppressing T cell-mediated inflammation [12, 17] . The role of B cell-mediated regulation in H. pylori infection and subsequent induction of gastric cancer, however, was not previously studied.
In this study, we analyzed the B cell composition and cytokine expression profile in H. pylori-infected subjects. smoking and obese subjects were found to exhibit loss of suppressive function when co-cultured with autologous T cells and stimulated reduced levels of IL-10 after direct H. pylori stimulation. In addition, in smoking and obese patients who later developed gastric cancer, the frequencies of IL-10-secreting B cells were further reduced, compared to the subjects who did not develop gastric cancer. Altogether, these data demonstrated that CD24 + CD38 + B cells were upregulated in H. pylori-infected and had functionally suppressed T cell inflammatory cytokine production. The CD24 + CD38 + B cells in smoking subjects and obese subjects, however, were refractory to H. pylori-stimulation, produced less IL-10, and lacked suppressive capacity.
Materials and Methods

Study subjects
Primary peripheral blood samples were obtained from 55 H. pylori-infected ulcer-free patients, of which 15 are primary consumers of tobacco smoke and 15 are class I obese (30kg/m 2 < BMI < 35 kg/m 2 ) subjects, as well as 15 healthy H. pylori-uninfected ulcer-free individuals. Individuals with chronic exposure to secondhand smoking were excluded from the study. No significant differences regarding age, sex, and previous infection history between study groups were found. All subjects were followed for 5 years for the cancer development status. All subjects were unrelated individuals from Henan province and its surrounding region. Patients were recruited between Jan 2008 and Dec 2013 from The 155th Central Hospital of PLA in China. Controls were cancer-free individuals randomly selected from a community cancer-screening program for early detection of cancer carried out in the same regions during the same period the patients were recruited. The response rate for both controls and cases was 95%. The selection criteria for healthy controls included cancer-free individuals and frequency matching to cases by sex and age (±5 years). At recruitment, written informed consent was obtained from each subject and personal data such as sex, age, weight, height and tobacco smoking were collected through a questionnaire. Not all subjects' samples were used in all experiments due to incomplete patient compliance and insufficient cells in some patients. This study was approved by Institutional Review Board of The 155th Central Hospital of PLA.
Sample preparation
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood samples with standard Ficoll-Hypaque procedure and frozen immediately at -150°C until use, or used in experiments immediately if noted. Regular culture medium is RPMI-1640 supplemented with 10% fetal bovine serum, 5mL of 100U penicillin/0.1 mg/mL streptomycin, and 5mL of 2mM L-glutamine. Cells were cultured in 5% CO 2 at 37°C for the stated period of time.
Cell isolation
T and B cells were isolated using Human T Cell or B cell Negative Selection Kit (Stemcell, Vancouver, Canada), following protocols provided by the manufacturer. The purities of T and B cell isolations were greater than 94% by flow cytometry. 
Flow cytometry
The following anti-human monoclonal antibodies were used: IL-10, TNF-a (eBioscience, San Diego, CA, USA); CD3, CD4, CD19, CD20, CD21, CD24, CD27, CD38 (Biolegend, San Diego, CA, USA); IFN-g (BD Biosciences, San Jose, CA, USA); CD8 (Invitrogen, Grand Island, NY, USA). Purified human IgG (Biolegend, San Diego, CA, USA) was used to block Fc receptors when staining populations containing B cells. For some experiments, phorbol-12-myristate-13-acetate (PMA, Sigma), ionomycin (Sigma, Munich, Germany), or heat-killed H. pylori (Sigma, Munich, Germany) were used to stimulate cells. GolgiStop and GolgiPlug were added 6h prior to cell harvest for intracellular staining of IL-2, IL-17, IFN-g, TNF-a, and IL-10. FlowJo was used to flow cytometry analysis.
Luminex assay
IL-2, IL-17, IFN-g, TNF-a and IL-10 from T cells and B cells were quantitatively measured by multiplex Luminex assay following protocols provided by manufacturer with modifications (EMD Millipore, Etobicoke, Canada). A total of 2x10 5 T cells and/or B cells were plated in each well of 96-well plate (Corning, Tewksbury, MA, USA). For B cell stimulation, heat-killed H. pylori were added to the B cells, which were plated at the bottom of a 96-well transwell plate (Corning, Tewksbury, MA). For T cell stimulation, the bottom part of the transwell plate was pre-incubated with anti-human CD3 (clone OKT3) overnight and washed, after which purified T cells were transferred into the plate. Human cytokine capture antibody beads were added to the upper chamber of the 96-well transwell plate. Twelve hours later, the beads were harvested, washed and read according to manufacturer's protocol.
Statistical analysis
D'Agostino and Pearson omnibus normality test was used to examine whether the data were normally distributed. One-way analysis of variance (ANOVA) was used for comparisons between multiple groups followed by Dunn's test. Student's t test was used for comparisons between two groups. If datasets significantly deviated from normal distribution, nonparametric tests were used. All statistical analyses were done using Prism (GraphPad Software). P<0.05 was considered significant. Results were shown as mean±S.E.M.
Results
H. pylori-infected subjects had altered circulating B cell composition
To analyze the potential changes in the role of B cell responses in H. pylori infection and how it might be affected by smoking and obesity, 15 healthy H. pylori-uninfected (H. pylori-uninfected) volunteers, 20 H. pylori-infected asymptomatic non-smoking non-obese (asymptomatic) subjects, 15 H. pylori-infected smoking non-obese (smoking) subjects, and 15 H. pyloriinfected non-smoking obese (obese) subjects were recruited for this study. The demographic and clinical data were summarized in Table 1 [15, 18] . We first examined the composition of circulating B cells in H. pylori-infected subjects. Peripheral blood mononuclear cells (PBMCs) were stained for surface marker expression directly ex vivo (Fig 1A) . We found that The percentage of CD24 + CD38 + B cells was reduced in smoking subjects compared to that in asymptomatic subjects (P<0.05), but still higher than that in healthy subjects (P<0.001). In obese subjects, the percentage of CD24 + CD38 + B cells was not significantly different from that in healthy subjects but was reduced from that in asymptomatic subjects (P<0.001).
H. pylori-infected subjects had altered B cell cytokine expression profile
Previously, B cells were found to amplify or suppress immune responses through the production of a series of cytokines with different functions, including pro-inflammatory cytokines such as IL-2, IL-4, IL-6, IL-12, IFN-g and TNF-a, as well as IL-10 and transforming growth factor beta (TGF-b) as regulatory cytokines [19] . Here, we examined the cytokine expression of B cells in study subjects. We found that the ex vivo expression of IL-2, IFN-g and TNF-a by B cells were increased in H. pylori-infected smoking subjects and obese subjects than that in healthy subjects (Fig 2A) . No significant differences were found in TGF-b expression. CD24 + CD38 + B cells have regulatory functions in other studies and had interesting expression levels in different H. pylori-infected groups (Fig 1C) . We examined the intracellular cytokine expression by CD24 H. pylori-infected asymptomatic subjects had more tolerogenic activity mediated by CD24 + CD38 + B cells than smoking and obese subjects [14, 20] , by establishing tolerogenic (Fig 3A) . In smoking subjects and obese subjects, such effect was not observed. Similarly, CD8 + T cells from H. pylori-infected asymptomatic subjects co-cultured with autologous CD24 + CD38 + -depleted B cells significantly enhanced IFN-g and TNF-a secretion than those co-cultured with whole B cells (Fig 3B) . Again, such effect was not observed in smoking subjects and obese subjects. 
Regulatory B cells were known to inhibit T cell responses in chronic infections, such as hepatitis B infection and human immunodeficiency virus infection
IL-10 secretion by CD24+CD38+ B cells upon H. pylori stimulation in different subjects
We next sought to examine the mechanism of IL-10 upregulation in the B cells of H. pyloriinfected subjects. IL-10 production is pivotal to regulatory B cell function [12, 13] . Toll-like receptor signaling is a major IL-10 upregulation mechanism in B cells, and was shown to modulate cytokine expression in H. pylori infection [22, 23] . We tested whether the presence of H. pylori can directly upregulate IL-10 secretion in CD24 Gastric cancer-positive patients in the H. pylori-infected smoking and H. pylori-infected obese groups had lower frequencies of IL-10 + B cells
Smoking and obesity were known to increase the risk for gastric cancer development in H. pylori-infected subjects. Since smoking and obesity also suppressed normal regulatory B cell functions, we examined whether these two phenomena were linked. We found that in smoking subjects and obese subjects, those who became positive for gastric cancer status had tion than those who remained negative for gastric cancer development (Fig 5A. P<0 .05 for both). On the other hand, we did not find that cancer positive and cancer negative patients were significantly different in terms of their frequencies of CD24 + CD38 + B cells in total B cells (Fig 5B) . No H. pylori-infected asymptomatic patients in this study became gastric cancer positive.
Discussion
H. pylori infection is the major cause of the development of gastric cancer. Although the majority of infections were asymptomatic and treatable, a subset of subjects fails treatment and progress to gastric cancer. In addition, smoking and obesity increase the risk of cancer development while the mechanisms are not entirely clear. In this study, we first observed an alteration in circulating B cell composition in H. pylori-infected asymptomatic subjects compared to Together, these data demonstrated that H. pylori-infected subjects had upregulated frequencies of circulating CD24 + CD38 + B cells, which expressed high levels of IL-10 and exhibited regulatory function. Interestingly, in H. pylori-infected smoking subjects and obese subjects, the circulating CD24 + CD38 + B cells were reduced in frequency compared to H. pylori-infected asymptomatic subjects, were unable to suppress T cell pro-inflammatory cytokine production in co-culture experiments, and did not significantly upregulate IL-10 expression after H. pylori stimulation. In addition, we followed the subjects for five years and subsequently found that compared to gastric cancer-positive patients, gastric cancer-negative patients had more IL-10 production after H. pylori stimulation. Chronic cell destruction and tissue lesions in persistent H. pylori infection were major contributing factors to gastric cancer development [24] . From results presented in this paper, it is possible that increased IL-10-expression by B cells may protect the H. pylori-infected subjects by reducing T cell-mediated inflammation and limiting tissue lesions, but in smoking subjects and obese subjects, the B cell-mediated tissue protection was not present. More studies are needed in the future to examine whether the presence of IL-10 + B cells is correlated with reduced tissue lesions in H. pylori infection. This, however, was not feasible in this study since it requires gastric tissue samples.
It has been reported that tobacco smoking is associated with increased oxidative stress and pro-inflammatory cytokine release, possibly due to smoking-induced tissue damage [25, 26] . Obesity is also associated with increased low-grade, chronic inflammation [27] . In this study, we found that H. pylori-infected smoking subjects and obese subjects had less IL-10 + B cells than H. pylori-infected asymptomatic subjects. Subsequently, unlike that in asymptomatic subjects, presence of CD24 + CD38 + B cells from smoking subjects and obese subjects in the T cell-B cell co-culture did not reduce T cell pro-inflammatory cytokine production. The reduction in IL-10 production and the lack of regulatory function in B cells may have resulted from the overall increased inflammatory state in smoking and obesity. Indeed, our data showed that B cells from H. pylori-infected smoking and obese subjects, but not those from asymptomatic subjects, had higher IL-2, IFN-g, and TNF-a production than B cells from uninfected healthy subjects, suggesting a skewing toward a more proinflammatory phenotype. At the same time, exposure to chronic smoking and obesity are known to associate with increased gastric cancer risk. Together, these data suggest that a more pro-inflammatory immune profile in smoking and obese population may contribute to gastric cancer development.
Due to the lack of regulatory B cell-specific transcription factors and surface molecules, various non-specific sets of surface markers, including CD1d hi CD5 + , CD19 + CD24 hi CD38 hi , and CD19 + TIM-1 + , had been used in previous studies to denote B cells with regulatory activities [15, 22, 28, 29] . In this study, we focused on CD24 + CD38 + -expressing B cells because we found that IL-10, a pivotal cytokine in regulatory B cell function, is enriched in this subset, and Fig 3 has demonstrated that this subset had regulatory activity in suppression T cell cytokine production. This choice of surface markers, however, did have caveats, since CD19 + CD24
hi CD38 hi were previously described as immature/transitional B cells [30, 31] . B cells can act as important antigen-presenting cells and were found to support T cell subpopulation differentiation and maintenance [32] . At this point, it is unknown whether CD24 + CD38 + B cells in our study were potentially immature/transitional B cells, which may be less effective at antigen presentation.
To prevent this problem, we compared whole B cells with CD24 + CD38 + -depleted B cells (both groups with mature B cells capable of "normal" antigen presentation), and subsequently restimulated T cells with anti-CD3 for direct T cell receptor (TCR) activation. Although we also included a CD24 + CD38 + B cell-only group in the co-culture experiment, and found that T cells in these co-cultures had significantly reduced proinflammatory cytokine production than T cells in CD24 + CD38 + B cell-depleted cocultures, we cannot exclude the possibility that this reduction were due to potentially defective antigen presentation during the co-culture, prior to direct TCR activation. The role of regulatory cells in the immune system was frequently seen as a double-edged sword in chronic infections. On one hand, the suppression of inflammation by regulatory T cells and B cells can prevent excessive tissue damage mediated by the immune system. On the other hand, regulatory T cell and B cell-mediated inhibition of immune activation were thought to contribute to pathogen persistence, effector T cell exhaustion, and lowered ability to clear infections. Previously, IL-10-secretion in B cells was found to contribute to Salmonella typhimurium and mouse mammary tumor virus persistence in mice and HIV persistence in humans [20, 33, 34] . In this study, we found that addition of H. pylori could directly activate B cell IL-10 production, but it is unclear how the upregulation of CD24 + CD38 + B cells and IL-10 secretion can affect H. pylori infection. Whether regulatory B cells contribute to bacterial persistence in H. pylori infection requires more studies.
